Harmony Biosciences Holdings, Inc. (HRMY) vs Recursion Pharmaceuticals, Inc. (RXRX)
- Harmony Biosciences Holdings, Inc. HRMY 38.20 −0.18%
- Recursion Pharmaceuticals, Inc. RXRX 3.47 −16.59%
Harmony Biosciences Holdings, Inc. and Recursion Pharmaceuticals, Inc. are both Biotechnology companies. Harmony Biosciences Holdings, Inc. and Recursion Pharmaceuticals, Inc. are of similar size ($2.2B and $2.2B). Recursion Pharmaceuticals, Inc. has negative trailing earnings, so its P/E is not meaningful; Harmony Biosciences Holdings, Inc. trades at 12.2×. Harmony Biosciences Holdings, Inc. grew revenue faster over the last twelve months: 24.3% against −15.1%. Harmony Biosciences Holdings, Inc. has the higher net margin (18.9% vs −945.9%) and the higher return on invested capital (29.7% vs −92.2%). Across the 18 metrics below, Harmony Biosciences Holdings, Inc. leads on 13 and Recursion Pharmaceuticals, Inc. on 5.
Valuation
Profitability
| Metric | HRMY | RXRX | Biotechnology median |
|---|---|---|---|
| Gross margin | 75.42% | 3.48% | 65.16% |
| Operating margin | 24.03% | (991.72%) | 0.00% |
| Net margin | 18.88% | (945.92%) | 0.00% |
| Free cash flow margin | 36.99% | (645.82%) | 0.00% |
| Return on equity | 20.46% | (56.58%) | (56.36%) |
| Return on assets | 14.61% | (41.26%) | (48.04%) |
| Return on invested capital | 29.70% | (92.22%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack